Roxanol and Temodar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Roxanol (morphine sulfate) and Temodar (temozolomide). Common drug interactions include atelectasis among females and abdominal pain lower among males.

The phase IV clinical study analyzes what interactions people have when they take Roxanol and Temodar. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Roxanol?

Roxanol has active ingredients of morphine sulfate. eHealthMe is studying from 807 Roxanol users. Check the latest studies of Roxanol.

What is Temodar?

Temodar has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 6,683 Temodar users. Check the latest studies of Temodar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

16 people who take Roxanol and Temodar together, and have interactions are studied.

What are the common drug interactions of Roxanol and Temodar, by gender? *:

female:

Atelectasis (partial or complete collapse of the lung)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Back pain
Blood creatinine increased
Bone disorder
Bone fissure
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bruxism (habitual grinding of the teeth, typically during sleep)
Cellulitis (infection under the skin)
Cerebral infarction (less blood supply to brain resulting tissue damage)

male:

Abdominal pain lower
Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)

What are the common drug interactions of Roxanol and Temodar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Blood lactate dehydrogenase increased
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Bone disorder
Bone fissure
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bruxism (habitual grinding of the teeth, typically during sleep)
Cellulitis (infection under the skin)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Confusional state
Culture urine positive

What are the existing conditions these people have? *

Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 4 people, 25.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 25.00%
Pulmonary Tuberculosis (lungs tuberculosis): 1 person, 6.25%
Pain: 1 person, 6.25%
Insomnia (sleeplessness): 1 person, 6.25%
Histiocytosis Haematophagic: 1 person, 6.25%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 6.25%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Roxanol and Temodar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously